Tempest Therapeutics, Inc. (TPST) — DEF 14A Filings
All DEF 14A filings from Tempest Therapeutics, Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Tempest Therapeutics Seeks Shareholder Approval for Key Strategic Moves
— Dec 31, 2025 Risk: high
Tempest Therapeutics, Inc. (TPST) is holding its Annual Meeting on January 27, 2026, where stockholders will vote on several critical proposals. Key among these -
Tempest Therapeutics Files Definitive Proxy Statement
— Nov 12, 2024 Risk: low
Tempest Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on November 12, 2024, for its annual meeting on December 3, 2024. The company, formerl -
Tempest Therapeutics Announces 2024 Annual Meeting of Stockholders on June 13
— Apr 23, 2024 Risk: low
Tempest Therapeutics, Inc. (TPST) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Annual Meeting of Stockholders to be held virtually on June
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX